Vimarsana
Biggest News Aggregation in the World

Page 3 - Sergey Young News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sergey Young. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sergey Young Today - Breaking & Trending Today

Tag: exercise – NBC 5 Dallas-Fort Worth - Vimarsana News

Tag: exercise – NBC 5 Dallas-Fort Worth

Articles from the tag: exercise

Source: nbcdfw.com
Health – NECN - Vimarsana News

Health – NECN

News, Local News, Weather, Traffic, Entertainment, Breaking News

Source: necn.com
Will Biohacking Really Help You Live Longer? Inside the Health Trend - Vimarsana News

Will Biohacking Really Help You Live Longer? Inside the Health Trend

Luke Storey commits his first hack at dawn—precisely when the sun crests the horizon at a 30-degree angle, providing a supercharged light that he swears optimally dials his circadian rhythm and neurotransmitters. Sungazing is often followed by a ten-minute plunge in an industrial freezer full of 40-degree water—a jerry-rigged ice bath. After toweling off, the rangy, six-foot-three 50-year-old then ascends to the top of his Laurel Canyon property where he has converted a toolshed into a new-age gym that looks like it was outfitted by someone who has watched the Iron Man trilogy a few too ...

Source: lamag.com
LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing - Vimarsana News

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing

LyGenesis Receives FDA Clearance to Begin Phase 2a Trial of its Cell Therapy for Patients with End Stage Liver Disease, and also Closes $11 Million Convertible Debt Financing News provided by Share this article Share this article PITTSBURGH, Dec. 30, 2020 /PRNewswire/ -- LyGenesis, Inc., a biotechnology company developing cell therapies that enable organ regeneration, announced today that the U.S Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application. Under the IND, LyGenesis will be conducting a Phase 2a study on the safety, tolerability, and efficacy...